[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@PJamess69
"$MDGL They have only $277m left remaining $150m is optional. So not much left to do BD and they need more $$ for Europe launch and to fund F4c trial.BD possibility is very very low.BD is not easy for madrigal" @PJamess69 on X 2025-07-26 23:07:03 UTC XXX followers, XXX engagements
"@monaco_biotech Have you noticed this $PFE Pfizer (PFE) is also scheduled to release its Q2 2025 earnings report on August X 2025 before the market opens" @PJamess69 on X 2025-07-25 12:17:23 UTC XXX followers, XX engagements
"$MRK $XBI Mercks current pipeline includes efinopegdutide a GLP-1/glucagon agonist in Phase X for MASH but it lags behind Rezdiffra. Acquiring $MDGL Madrigal would provide Merck with a market-leading approved asset complementing its cardiometabolic focus" @PJamess69 on X 2025-07-22 01:22:09 UTC XXX followers, XXX engagements
"@yaireinhorn @TimOpler @Stifel @VerveTx @EliLillyandCo @Merck @BiotechCH @bradloncar @Maximus_Holla @unusual_whales @yaireinhorn which is next buyout candidate" @PJamess69 on X 2025-07-27 01:36:46 UTC XXX followers, XX engagements
"All Bio potential Buyout Stocks strong today $BBIO $TGTX $CYTK $MDGL $XBI" @PJamess69 on X 2025-07-14 16:13:24 UTC XXX followers, XXX engagements
"@bioinvestor24 @WallStSai $MDGL next to get bought out by BP" @PJamess69 on X 2025-07-13 18:39:03 UTC XXX followers, XXX engagements
"@Jabroni_16 @GYuengling24986 @MadrigalPharma where is the buyout" @PJamess69 on X 2025-07-24 20:42:00 UTC XXX followers, XX engagements
"@bioinvestor24 @badinvestor99 @Matthew_ABCD This is crazy.no competition for MASH . $MDGL is the first mover and has big advantage with it.CEO need to sell the company to $PFE or $BMY if he doesnt risk of company falling into competition from 2027.why take that risk Sell it" @PJamess69 on X 2025-07-25 20:45:33 UTC XXX followers, XXX engagements
"@mroliverbarnes Nice reporting bro @mroliverbarnes 🙏🏼 Love your M&A reports. Which is next in your list $BBIO $VKTX $MDGL" @PJamess69 on X 2025-07-13 18:43:03 UTC XXX followers, XXX engagements
"$MDGL With FDA approval already in hand and now robust IP protection Madrigal may have: - First-mover advantage in a multibillion-dollar market - A long runway of commercial exclusivity - A strategic edge in future partnerships M&A or pricing power" @PJamess69 on X 2025-07-21 01:10:53 UTC XXX followers, XXX engagements
"$MDGL Blowout Quarter is Obvious and Buyout is also Obvious 😍" @PJamess69 on X 2025-07-23 18:50:35 UTC XXX followers, XXX engagements